Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topics that matter most, balances emerging trends with scientific evidence, and reflects the growing importance of longevity within modern healthcare.

They explore the difference between healthy ageing—grounded in well-established principles such as sleep, nutrition, exercise, stress management and social connection—and the consumer longevity movement, where interventions are often expensive, and the supporting evidence is still evolving.

The conversation examines the gap between health insights and meaningful behaviour change, asking why biomarker data alone rarely translates into better health outcomes. They also discuss whether healthcare systems and insurers are likely to invest more in preventative healthcare beyond wearables and lifestyle programmes.

Other topics include the importance of social health and loneliness, the evidence gap in women’s health, why strength should take priority over the pursuit of being “small”, the opportunities and limitations of GLP-1 medicines, longevity’s communication challenge, and how artificial intelligence could reshape primary care and expand access to preventative healthcare. HLTH and Longevity: Healthy Ageing, Evidence and Women’s Health

Beyond Longevity examines how longevity has moved from a niche topic into mainstream healthcare, using HLTH’s major US and Europe conferences as a bellwether. Host Daphna speaks with HLTH head of content, Jody Tropeano Greene and HLTH US content lead, Alexa Mikhail, about how they build agenda programming that surfaces trending issues while insisting on credible evidence, and why they are dedicating a full day to longevity.

They distinguish healthy ageing (population-level, researched basics such as sleep, nutrition, movement, stress and relationships) from consumer longevity biohacking (often expensive and sometimes unproven), discuss the “insight–action gap” from biomarker data, and debate whether insurers will fund prevention beyond wearables and lifestyle supports.

HLTH USA is the premier event taking place November 15-18 in Las Vegas, where leaders from across the healthcare ecosystem come together to share insights, spark inspiration, and shape the global health agenda. Attendees gain a comprehensive view of healthcare advancements, from policy and market dynamics to cutting-edge consumer health technologies - all aimed at improving the well-being of individuals worldwide.

Register and save $1,000+ by Friday, July 31

https://hlth.com/

Jody Tropeano Greene

Head of Content, HLTH

https://www.linkedin.com/in/jodytropeano/

Alexa Mikhail

Content Lead, HLTH US

Senior health and longevity writer, SHE Media, Flow Space

https://www.linkedin.com/in/alexamikhail/

00:00 Welcome to Beyond Longevity

00:25 Why HLTH Matters

01:26 Meet Jody and Alexa

03:02 How HLTH Picks Topics

04:41 Healthy Ageing vs Longevity

07:51 Credibility Over Hype

09:05 When Trends Go Mainstream

11:49 Prevention and Insurance

15:58 Loneliness as Longevity

17:05 What Makes Startups Break Through

19:19 Women Left Out of Data

23:44 Strength Over Smallness

26:41 Practical Healthspan Habits

27:45 Elevating Women's Health

29:19 Building Consumer Wellness

31:24 Longevity Goes Mainstream

32:21 Making Basics Profitable

34:17 Longevity Language Problem

35:24 Preparedness And Community

38:45 GLP1 Promise And Risks

42:13 Healthcare In Ten Years

45:17 Assumptions To Challenge

47:22 Rapid Fire And Wrap

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(31)

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Aug 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Aug 48min

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving fr...

26 Jul 1h 2min

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

On Beyond Longevity, host Daphna speaks with Dr Sundeep Dugar, PhD, co-founder of BlueOakNx and the scientists behind the blockbuster cholesterol medicines Zetia (ezetimibe) and Vytorin. He explains h...

12 Jul 59min

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switz...

5 Jul 1h

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientif...

28 Jun 57min

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Beyond Longevity interviews Kyle Holbert, COO and co-founder of Longevity Centres of America, about how unexplained fatigue, brain fog, depression, anxiety, joint pain and gut issues derailed his heal...

21 Jun 57min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
abels-tarn
liberal-halvtime
romkapsel
jss
rekommandert
vett-og-vitenskap-med-gaute-einevoll
sinnsyn
dekodet-2
villmarksliv
fjellsportpodden
rss-rekommandert
tomprat-med-gunnar-tjomlid
rss-inn-til-kjernen-med-sunniva-rose
rss-nysgjerrige-norge
rss-overskuddsliv
diagnose
abid-nadia-skyld-og-skam
forskningno